Cystitis clinical trials

Explore recruiting cystitis clinical trials.

Recruiting cystitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cystitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Multicentre, randomised, double-blind, placebo-controlled clinical trial to confirm the efficacy, safety, and clinical impact of the mucosal bacterial therapeutic vaccine MV140 in women with non-complicated recurrent urinary tract infections (rUTIs).

Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

OBI-WAN : Obinutuzumab for remission induction in patients with relapsing PR3-ANCA granulomatosis with polyangiitis (Wegener’s). Phase 2 prospective, open-label study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

E-merge - Evaluation of MEpolizumab-based regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, randomized, controlled, double-blind study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administration of 2% and 4% lidocaine gel into the urethra

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Cystitis trials by city

Cystitis in Toronto Cystitis in Vancouver Cystitis in Montreal Cystitis in Calgary Cystitis in Edmonton Cystitis in Ottawa Cystitis in Winnipeg Cystitis in Quebec City Cystitis in Hamilton Cystitis in Kitchener Cystitis in London Cystitis in Halifax Cystitis in New York Cystitis in Los Angeles Cystitis in Chicago Cystitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease